Publications To Date


    Filter Publications

    PAGE 1 OF 75 | DISPLAYING 1 - 15 OF 1112 RESULTS

    Das K et al., Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue., , Methods Mol Biol, Jan 01, 2020

    Cesano A et al., Status of Immune Oncology: Challenges and Opportunities., , Methods Mol Biol, Jan 01, 2020

    Beechem JM et al., High-Plex Spatially Resolved RNA and Protein Detection Using Digital Spatial Profiling: A Technology Designed for Immuno-oncology Biomarker Discovery and Translational Research., , Methods Mol Biol, Jan 01, 2020

    Croce S et al., The NanoCind® signature is an independent prognosticator of recurrence and death in uterine leiomyosarcomas., , Clin Cancer Res, Nov 26, 2019

    Rashid et al., Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer, , Clin Cancer Res, Nov 21, 2019

    Fong L et al., Adenosine A2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer, , Cancer Discovery, Nov 15, 2019

    Liu B et al., PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer, , Clin Cancer Res, Nov 15, 2019

    Long Y et al., Dysregulation of glutamate transport enhances Treg function that promotes VEGF blockade resistance in glioblastoma, , Cancer Res, Nov 13, 2019

    Zhong Y et al., Multiplexed Digital Detection of B-cell Acute Lymphoblastic Leukemia Fusion Transcripts Using the NanoString nCounter System., , J Mol Diagn, Nov 13, 2019

    Mhawech-Fauceglia P et al., Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature., , Gynecol Oncol, Nov 08, 2019

    Damotte D et al., The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort., , J Transl Med., Nov 04, 2019

    Yu J et al., Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma., , Clin Cancer Res, Nov 01, 2019

    Giannini R et al., Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like., , J Clin Endocrinol Metab, Oct 28, 2019

    Hicks KC et al., Cooperative Immune-mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL-15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy, , Clin Cancer Res, Oct 23, 2019

    Luminari S et al., A gene expression-based model to predict metabolic response after two courses of ABVD in Hodgkin Lymphoma patients, , Clin Cancer Res, Oct 23, 2019